Loading clinical trials...
Loading clinical trials...
RATIONALE: Understanding why sunbathers use or don't use sunless tanning products may help doctors plan effective ways to prevent skin cancer caused by sunbathing. PURPOSE: This phase I/II trial is studying attitudes about the use of sunless tanning products and how well sunless tanning products work as a substitute for sunbathing in healthy participants.
OBJECTIVES: Primary * Determine participants' attitudes regarding the benefits and barriers to using sunless tanning products after having sampled them. (Phase I) * Determine participants' opinions, suggestions, and preferences regarding use of sunless tanning products. (Phase I) * Determine the validity and reliability of the Sunless Tanning Attitudes Survey. * Determine time spent sunbathing in random beach-goers. (Phase II) Secondary * Determine sunburn frequency in random beach-goers. (Phase II) * Determine the use of a sunless tanner in these participants. (Phase II) * Determine sun protection use in these participants. (Phase II) * Determine perceptions of sun protection, susceptibility to photoaging, benefits of sunbathing, and severity of photoaging. (Phase II) OUTLINE: This is an open-label phase I study followed by a pilot, randomized, controlled phase II study. * Phase I (focus group): Participants complete the Sunless Tanning Attitudes (STA) survey, Sun Behavior (SB) survey, and the Decisional Balance for Sun Exposure and Sun Protection Questionnaire. Participants who have used a sunless tanner in the past also complete the Sunless Tanner Users (STU) survey. Participants receive sunless tanning lotion and instructions for its use. Participants are instructed to use the sunless tanner for 2 weeks (≥ 3 applications). Participants then complete the STA, SB, and STU surveys and participate in a focus group. * Phase II:Participants are stratified by beach location and randomized to 1 of 2 intervention arms. * Arm I: Participants complete surveys as in phase I. Photographs are taken of the participants and they then receive sunscreen lotion and sunless tanning lotion and instructions and benefits for using both. Participants also receive an educational pamphlet regarding skin cancer. * Arm II: Participants complete surveys as in phase I. A souvenir photograph is taken of the participants and they then receive product samples that are irrelevant to skin cancer risk reduction (e.g., skin moisturizer, hair gel, chewing gum). Participants also receive educational materials at the completion of the study. In both arms, participants complete surveys again at 2 and 12 months. PROJECTED ACCRUAL: A total of 330 participants will be accrued for this study.
Age
18 - 120 years
Sex
ALL
Healthy Volunteers
Yes
University of Massachusetts Medical School
Worcester, Massachusetts, United States
Start Date
April 1, 2006
Primary Completion Date
December 1, 2007
Completion Date
December 1, 2007
Last Updated
October 1, 2015
307
ACTUAL participants
Intervention
BEHAVIORAL
Lead Sponsor
University of Massachusetts, Worcester
Collaborators
NCT05702398
NCT07266142
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04844528